Biologics Flashcards

1
Q

Traditional drugs

A
  • synthetic organic compounds
  • defined structure, physical and chemical characteristics
  • small MW
  • linear dose response
  • biotransformed
  • NOT species specific
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Biologics

A
  • protein, carb, nucleic acid structures
  • extracted from living organism
  • large MW
  • heat and shear sensitive
  • non linear dose response
  • species dependent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

u

A

human

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

o

A

mouse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

xi

A

chimeric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

zu

A

humanized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Biologics elimination

A

RES

antigen specific target mediated disposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Common side effects of biologics

A
  • infusion site reactions
  • allergic reactions
  • flu like symptoms
  • N/D
  • decreased blood cell counts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Etanercept

A
  • anti-TNF
  • TNF receptor
  • shortest DOA
  • RA, psoriasis, psoriatic arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side effects etanercept

A

Ha, allergic reaction, rash, URI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BBW anti TNF drugs

A

for serious infections, malignancies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Infliximab

A
  • anti-TNF
  • partially humanized
  • Crohn’s disease, ulcerative colitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Infliximab side effects

A

CV effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

adalimumab

A
  • anti-TNF

- fully humanized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adalimumab side effects

A
  • develop antibodies against drug

- cause demyelination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CI adalimumab

A

patients with demyelinating diseases (MS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

bevacizumab

A
  • angiogenesis inhibitor
  • stops formation of new blood vessels, inhibit VEGF
  • treat cancers, eye diseases
18
Q

BBW bevacizumab

A

hemorrhage, delayed wound healing and GI perforations

19
Q

Abciximab

A
  • GPIIb/IIIa antagonist
  • prevent platelet aggregation
  • percutaneous coronary intervention
20
Q

Side effects abciximab

A
  • bleeding
  • thrombocytopenia
  • allergy
21
Q

Omalizumab

A
  • IgE inhibitor

- moderate to severe asthma

22
Q

BBW omalizumab

A

for anaphylaxis presenting as bronchospasm

23
Q

side effects omalizumab

A
  • injection site reactions

- CV events

24
Q

Pembrolizumab

A
  • Block PD1
  • humanized
  • cancers
25
Q

Side effects pembrolizumab

A
  • rash (SJS)
  • fatigue
  • T1D
26
Q

Nivolumab

A
  • block PD1
  • fully human
  • metastatic cancer
27
Q

Side effects of nivolumab

A
  • Rash (SJS)
  • adrenal insufficiency
  • T1D
  • GI toxicity: diarrhea, colitis
28
Q

What can nivolumab be used with?

A

ipilimumab (synergistic)

- metastatic melanoma

29
Q

Atezolizumab

A
  • block PD-L1
  • humanized
  • metastatic lung cancer
  • metastatic urothelial carcinoma
30
Q

Side effects of anti PD-L1 drugs

A
  • adrenal insufficiency
  • CV toxicity
  • T1D
  • infection risks
31
Q

avelumab

A
  • block PD-L1
  • fully human
  • Merkel cell carcinoma
  • advanced metastatic urothelial carcinoma
32
Q

durvalumab

A
  • block PD-L1
  • fully human
  • metastatic urothelial carcinoma
33
Q

Ipilimumab

A
  • CTLA-4 inhibitor
  • fully human
  • metastatic and non-metastatic melanoma
34
Q

BBW ipilimumab

A
  • immune mediated reactions (months to weeks after treatment stops)
35
Q

CTLA-4 inhibitor drugs

A

ipilimumab

36
Q

PD-L1 inhibitor drugs

A
  • atezolizumab
  • avelumab
  • durvalumab
37
Q

PD-1 inhibitor drugs

A
  • pembrolizumab

- nivolumab

38
Q

IgE inhibitor drugs

A
  • omalizumab
39
Q

Anti platelet drugs

A
  • abciximab
40
Q

Malignancies drugs

A
  • bevacizumab
41
Q

Anti-TNF drugs

A
  • etanercept
  • infliximab
  • adalimumab